Proteome Changes during Transition from Human Embryonic to Vascular Progenitor Cells

Area of Science:

• Stem cell biology
• Regenerative medicine
• Proteomics

Background:

• Human embryonic stem cells (hESCs) hold promise for regenerative medicine due to their differentiation capabilities.
• A critical hurdle in regenerative medicine is creating functional vascular systems for tissue support.
• Generating vascular progenitor cells from hESCs is essential for engineered vascularization.

Purpose of the Study:

• To refine methods for differentiating hESCs into CD34(+) vascular progenitor cells.
• To characterize the proteomic differences between hESCs, CD34(+) vascular progenitor cells, and CD34(-) cells.
• To identify protein markers associated with vascular cell differentiation and heterogeneity.

Main Methods:

• Differentiation of hESCs into CD34(+) vascular progenitor cells using defined media.
• Selective purification of CD34(+) cells from CD34(-) populations.
• Proteomic analysis using high-resolution mass spectrometry and label-free quantification.
• Multivariate analysis of proteomic data.
• Immunological assays to validate protein markers.

Main Results:

• Successfully differentiated hESCs into CD34(+) vascular progenitor cells.
• Identified 18 protein markers validating differentiated phenotypes, with 9 detected by proteomics and showing differential abundance.
• Detected 225 differentially abundant proteins between hESCs, CD34(+), and CD34(-) cells.
• CD34(+) cells showed proteins involved in endothelial and smooth muscle formation, supporting a bipotent phenotype.
• CD34(-) cells exhibited heterogeneity with markers for multiple lineages.

Conclusions:

• The refined method effectively generates vascular progenitor cells from hESCs.
• Proteomic profiling provides insights into the molecular mechanisms of vascular differentiation and cell heterogeneity.
• The study identifies novel proteins that can guide future research in vascular morphogenesis and regenerative medicine.